EP1803450A1 — Pharmaceutical compositions for the eradication of helicobacter pylori
Assigned to Ferrer Internacional SA · Expires 2007-07-04 · 19y expired
What this patent protects
A pellet composition for oral administration comprising simultaneously a proton pump inhibitor, a clarithromycin compound and an amoxicillin compound. Said compositions are suitable to be filled in sachets and are useful in the treatment of disorders associated with Helicobacter…
USPTO Abstract
A pellet composition for oral administration comprising simultaneously a proton pump inhibitor, a clarithromycin compound and an amoxicillin compound. Said compositions are suitable to be filled in sachets and are useful in the treatment of disorders associated with Helicobacter bacteria.
Drugs covered by this patent
- Amoxil (amoxicillin) · Generic (originally Beecham/GSK)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.